AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Interest Income Expense
AngioDynamics Inc
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AngioDynamics Inc
NASDAQ:ANGO
|
Interest Income Expense
$1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$419m
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$305m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-4%
|
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
-$257m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$188m
|
CAGR 3-Years
27%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-14%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$324.9m
|
CAGR 3-Years
67%
|
CAGR 5-Years
21%
|
CAGR 10-Years
54%
|
|
AngioDynamics Inc
Glance View
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
See Also
What is AngioDynamics Inc's Interest Income Expense?
Interest Income Expense
1.8m
USD
Based on the financial report for Nov 30, 2024, AngioDynamics Inc's Interest Income Expense amounts to 1.8m USD.
You don't have any saved screeners yet